Background: Merkel cell carcinoma is a rare cutaneous neoplasm which common
ly spreads to the regional lymph nodes. The feasibility of identifying the
sentinel node in patients with clinically node-negative Merkel cell carcino
ma was evaluated.
Methods: Sentinel lymphatic mapping was performed in 18 patients with stage
1 Merkel cell carcinoma using the combination of isosulphan blue dye and T
c-99m-radiolabelled sulphur colloid. Patients with tumour metastasis in the
sentinel node underwent complete dissection of the remainder of the lymph
node basin.
Results: Eighteen patients underwent removal of 35 sentinel nodes. Two pati
ents demonstrated metastatic disease in the sentinel lymph nodes; complete
dissection of the involved nodal basin revealed no additional positive node
s suggesting that the sentinel lymph node had been identified. The node-neg
ative patients received no further surgical therapy, with no evidence of re
current disease in the sentinel nodal basin at a median of 7 months' follow
-up.
Conclusion: Sentinel node biopsy is feasible in patients with Merkel cell c
arcinoma. It call be used to stage patients and provides important prognost
ic information. In those with subclinical nodal disease, it may direct earl
y regional lymphadenectomy but the effect of such surgery on survival remai
ns unclear.